Riskpilot← Back to searchSign inGet full accessPAREXEL DENMARK A/S
A/SActiveCVR 31588626H.C. Andersens Boulevard 38, 3. thOffice administrative and support activities · NACE 8210Est. 200822 employees
Revenue 2025
DKK 35M
-7% vs 2024
EBITDA margin
4.9%
-40% vs 2024
Equity ratio
39.4%
Financial strength
Net profit 2025
DKK 1,3M
-45% vs 2024
| Revenue | DKK 35M | -7% |
| EBITDA | DKK 1,7M | -40% |
| Net profit | DKK 1,3M | -45% |
| Total assets | DKK 48,3M | +114% |
| Equity | DKK 19M | +7% |
| Employees | 22 | — |
Legal name
PAREXEL DENMARK A/S
CVR number
31588626
Legal form
Aktieselskab
NACE code
8210 · Office administrative and support activities
Founded
1. juli 2008
Share capital
DKK 505.000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed inden for den farmaceutiske, biotekniske og medicinske produktionsindustri, herunder men ikke begrænset til kliniske forsøg, samt anden hermed forbundet virksomhed.
Address
H.C. Andersens Boulevard 38, 3. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 39.806 | 39.829 | 36.369 | 37.686 | 34.984 |
| Staff expenses | -24.334 | -26.057 | -25.780 | -22.013 | -26.155 |
| EBITDA | 3.085 | 3.175 | 1.465 | 2.815 | 1.703 |
| Depreciation & amort. | -154 | -330 | -353 | -189 | -36 |
| EBIT | 2.931 | 2.846 | 1.112 | 2.627 | 1.667 |
| Net financials | -93 | -56 | 274 | 396 | -9 |
| Profit before tax | 2.838 | 2.789 | 1.386 | 3.023 | 1.659 |
| Tax | 635 | 763 | 214 | 693 | 367 |
| Net profit | 2.203 | 2.027 | 1.172 | 2.330 | 1.292 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 26.339 | 18.593 | 19.149 | 22.563 | 48.295 |
| Equity | 12.227 | 14.253 | 15.425 | 17.756 | 19.047 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12.286 | 3.797 | 3.113 | 4.574 | 28.835 |
| Total debt | 12.286 | 3.797 | 3.113 | 4.574 | 28.835 |
EBITDA margin
4.9%
This company
15.8%
Market median
-69% vs market
20212025
Equity ratio
39.4%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
6.8%
This company
18.4%
Market median
-63% vs market
20212025
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
20212025
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20212025
Debt / equity
1.54×
This company
0.62×
Market median
-148% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TJ Founder | Founder | 2008 |
HM Management | Management | 2017 |
| Former (4) | ||
LH Management | Management | 2008 – 2010 |
LM Chief Executive Officer | Chief Executive Officer | 2010 – 2010 |
CM Chief Executive Officer | Chief Executive Officer | 2010 – 2014 |
MP Chief Executive Officer | Chief Executive Officer | 2014 – 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Chairman | 2017 | |
| Former (11) | ||
| Board of Directors | 2017 – 2019 | |
| Board of Directors | 2008 – 2018 | |
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2008 – 2013 | |
| Board of Directors | 2019 – 2025 | |
| Board of Directors | 2020 – 2024 | |
| Chairman | 2008 – 2013 | |
| Board of Directors | 2019 – 2020 | |
| Board of Directors | 2016 – 2017 | |
| Chairman | 2013 – 2017 | |
| Board of Directors | 2013 – 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PAREXEL DENMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lene Højland Eskildsen | Management | 0 companies |
| Tyge Jesper Rothe | Founder | 0 companies |
| Heidi Malene Juncher-Benzon | Management | 0 companies |
| Lynda Morgan | Chief Executive Officer | 0 companies |
| Camilla Middelboe | Chief Executive Officer | 0 companies |
| Marianne Puggaard Jensen | Chief Executive Officer | 0 companies |
| Richard Blake St. Francis, Jr. | Board of Directors | 0 companies |
| Josef H. von Rickenbach | Board of Directors | 0 companies |
| Martin Francis Mahoney, II | Board of Directors | 0 companies |
| Duncan Jamie Macdonald | Board of Directors | 0 companies |
| James F. Winschel, Jr. | Board of Directors | 0 companies |
| Luke Tristan Van Hengel | Board of Directors | 0 companies |
| Paul Joseph Armstrong | Board of Directors | 0 companies |
| Arno Oosterveld | Chairman | 0 companies |
| Joseph Edward Scott | Board of Directors | 0 companies |
| John Ronald James Benoit | Board of Directors | 0 companies |
| Emma Reeve | Board of Directors | 0 companies |
| Michael Francis Crowley, III | Chairman | 0 companies |
| Douglas Alexander Batt | Chairman | 0 companies |
| Ingo Dieter Bank | Board of Directors | 0 companies |